NASDAQ:ILMN - Illumina Stock Price, Price Target & More

Get Started

$266.22 -4.61 (-1.70 %)

(As of 05/25/2018 04:00 PM ET)

Previous Close$266.22

Today's Range$264.50 - $271.35

52-Week Range$167.98 - $273.93

Volume679,138 shs

Average Volume874,436 shs

Market Capitalization$39.94 billion

P/E Ratio66.56

Dividend YieldN/A

Beta0.86

About Illumina (NASDAQ:ILMN)

Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company operates in two segments, Core Illumina and Consolidated VIEs. It offers sequencing by synthesis technology that provides researchers with various applications and the ability to sequence mammalian genomes; and arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow the detection of known genetic markers on a single array. The company also provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and noninvasive prenatal testing, as well as products support services. It serves genomic research centers, academic institutions, government laboratories, and hospitals; and pharmaceutical, biotechnology, agrigenomics, and commercial molecular diagnostic laboratories, as well as consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. It operates in North America, Europe, Latin America, the Asia-Pacific region, the Middle East, and South Africa. The company has a strategic partnership with Loxo Oncology, Inc. to develop and commercialize a multi-gene panel for broad tumor profiling; and strategic collaboration with Bristol-Myers Squibb Company. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

Receive ILMN News and Ratings via Email

Sign-up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments

Sub-IndustryLife Sciences Tools & Services

SectorMedical

SymbolNASDAQ:ILMN

CUSIP45232710

Webwww.illumina.com

Phone858-202-4500

Debt

Debt-to-Equity Ratio0.23

Current Ratio2.71

Quick Ratio2.41

Price-To-Earnings

Trailing P/E Ratio66.56

Forward P/E Ratio54.67

P/E Growth2.79

Sales & Book Value

Annual Sales$2.75 billion

Price / Sales14.22

Cash Flow$5.2139 per share

Price / Cash51.06

Book Value$20.91 per share

Price / Book12.73

Profitability

EPS (Most Recent Fiscal Year)$4.00

Net Income$726 million

Net Margins19.31%

Return on Equity24.93%

Return on Assets13.72%

Miscellaneous

Employees6,200

Outstanding Shares147,000,000

Illumina (NASDAQ:ILMN) Frequently Asked Questions

What is Illumina's stock symbol?

Illumina trades on the NASDAQ under the ticker symbol "ILMN."

How were Illumina's earnings last quarter?

Illumina (NASDAQ:ILMN) issued its quarterly earnings results on Tuesday, April, 24th. The life sciences company reported $1.45 EPS for the quarter, beating the Zacks' consensus estimate of $1.02 by $0.43. The life sciences company earned $782 million during the quarter, compared to the consensus estimate of $744.30 million. Illumina had a return on equity of 24.93% and a net margin of 19.31%. Illumina's revenue was up 30.8% on a year-over-year basis. During the same period last year, the business posted $0.64 earnings per share. View Illumina's Earnings History.

When is Illumina's next earnings date?

Illumina is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for Illumina.

What guidance has Illumina issued on next quarter's earnings?

Illumina issued an update on its FY18 earnings guidance on Tuesday, April, 24th. The company provided earnings per share (EPS) guidance of $4.75-4.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.59. The company issued revenue guidance of +15-16% to ~$3.16-3.19 billion, compared to the consensus revenue estimate of $3.14 billion.

What price target have analysts set for ILMN?

19 analysts have issued 1-year target prices for Illumina's stock. Their forecasts range from $180.00 to $277.00. On average, they expect Illumina's share price to reach $252.0625 in the next twelve months. View Analyst Ratings for Illumina.

What are Wall Street analysts saying about Illumina stock?

Here are some recent quotes from research analysts about Illumina stock:

1. According to Zacks Investment Research, "In the last three months, Illumina outperformed its industry. The company’s recent strategic collaborations are expected to expand its product portfolio. This apart an improving margin scenario should also instill confidence on the stock. Currently, Illumina is focusing on product innovation through research and development as well, which is evident from the launch of iSeq 100 Sequencing System recently. Post a promising fourth-quarter show, we expect Illumina to maintain its growth momentum on continued uptake of sequencing consumables, instruments and microarray portfolios. On the flip side, the company is operating in a tough competitive landscape which is a concern. Further, the stock looks a bit overvalued at the moment." (4/16/2018)
2. Canaccord Genuity analysts commented, "Shipments to China grew +16% and we believe China is likely to be a double-digit grower for ILMN over the next several years, driven by the Chinese Precision Medicine Initiative," (8/7/2017)

Who are some of Illumina's key competitors?

Some companies that are related to Illumina include Agilent Technologies (A), Waters (WAT), Mettler-Toledo International (MTD), Bio-Rad Laboratories, Inc. Class B (BIO.B), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Integra Lifesciences (IART), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Quanterix (QTRX), Pacific Biosciences of California (PACB), Fluidigm (FLDM) and Harvard Bioscience (HBIO).

Who are Illumina's key executives?

Illumina's management team includes the folowing people:

Mr. Jay T. Flatley, Exec. Chairman (Age 65)
Mr. Francis A. deSouza, CEO, Pres & Director (Age 47)
Mr. Sam A. Samad, CFO & Sr. VP (Age 48)
Mr. Omead Ostadan, Exec. VP of Operations and Products (Age 46)
Mr. Marc A. Stapley, Exec. VP of Strategy & Corp. Devel. (Age 48)

Has Illumina been receiving favorable news coverage?

News headlines about ILMN stock have trended somewhat positive on Saturday, Accern reports. Accern scores the sentiment of press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Illumina earned a media sentiment score of 0.16 on Accern's scale. They also gave media stories about the life sciences company an impact score of 46.82 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Who are Illumina's major shareholders?

Illumina's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Baillie Gifford & Co. (12.02%), Edgewood Management LLC (3.51%), Winslow Capital Management LLC (0.64%), Prudential Financial Inc. (0.52%), American Century Companies Inc. (0.52%) and Legal & General Group Plc (0.45%). Company insiders that own Illumina stock include A Blaine Bowman, Charles Dadswell, Christian O Henry, Daniel Bradbury, Frances Arnold, Francis A Desouza, Jay T Flatley, Karin Eastham, Marc Stapley, Michel Bouchard, Mostafa Ronaghi, Oene Mark Van, Omead Ostadan, Robert S Epstein and Roy A Whitfield. View Institutional Ownership Trends for Illumina.

Which institutional investors are selling Illumina stock?

ILMN stock was sold by a variety of institutional investors in the last quarter, including Winslow Capital Management LLC, Baillie Gifford & Co., Sei Investments Co., Swiss National Bank, Reynders McVeigh Capital Management LLC, Van ECK Associates Corp, Guggenheim Capital LLC and New York State Common Retirement Fund. Company insiders that have sold Illumina company stock in the last year include A Blaine Bowman, Charles Dadswell, Frances Arnold, Francis A Desouza, Jay T Flatley, Karin Eastham, Marc Stapley, Michel Bouchard, Mostafa Ronaghi, Oene Mark Van, Omead Ostadan and Robert S Epstein. View Insider Buying and Selling for Illumina.

Which institutional investors are buying Illumina stock?

ILMN stock was purchased by a variety of institutional investors in the last quarter, including Federated Investors Inc. PA, Prudential Financial Inc., Rockefeller Capital Management L.P., Summit Trail Advisors LLC, Millennium Management LLC, Lord Abbett & CO. LLC, American Century Companies Inc. and Scout Investments Inc.. View Insider Buying and Selling for Illumina.

How do I buy shares of Illumina?

Shares of ILMN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Illumina's stock price today?

One share of ILMN stock can currently be purchased for approximately $266.22.

How big of a company is Illumina?

Illumina has a market capitalization of $39.94 billion and generates $2.75 billion in revenue each year. The life sciences company earns $726 million in net income (profit) each year or $4.00 on an earnings per share basis. Illumina employs 6,200 workers across the globe.

How can I contact Illumina?

Illumina's mailing address is 5200 ILLUMINA WAY, SAN DIEGO CA, 92122. The life sciences company can be reached via phone at 858-202-4500 or via email at [email protected]

MarketBeat Community Rating for Illumina (ILMN)

Community Ranking:		2.5 out of 5 ( )
Outperform Votes:		744 (Vote Outperform)
Underperform Votes:		729 (Vote Underperform)
Total Votes:		1,473

MarketBeat's community ratings are surveys of what our community members think about Illumina and other stocks. Vote "Outperform" if you believe ILMN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ILMN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Illumina (NASDAQ:ILMN) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

19 Wall Street analysts have issued ratings and price targets for Illumina in the last 12 months. Their average twelve-month price target is $252.0625, suggesting that the stock has a possible downside of 5.32%. The high price target for ILMN is $277.00 and the low price target for ILMN is $180.00. There are currently 1 sell rating, 4 hold ratings and 14 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.68	2.60	2.60	2.52
Ratings Breakdown:	1 Sell Rating(s) 4 Hold Rating(s) 14 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 6 Hold Rating(s) 13 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 6 Hold Rating(s) 13 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 8 Hold Rating(s) 12 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$252.0625	$247.2353	$242.1765	$198.5263
Price Target Upside:	5.32% downside	6.09% upside	9.99% upside	3.09% downside

Illumina (NASDAQ:ILMN) Consensus Price Target History

Price Target History for Illumina (NASDAQ:ILMN)

Illumina (NASDAQ:ILMN) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/7/2018	Barclays	Upgrade	Equal Weight ➝ Overweight	$235.00	High
4/25/2018	Morgan Stanley	Boost Price Target	Underweight ➝ Underweight	$170.00 ➝ $180.00	Medium
4/25/2018	BTIG Research	Reiterated Rating	Hold		High
4/25/2018	Robert W. Baird	Boost Price Target	Outperform ➝ Outperform	$261.00 ➝ $271.00	High
2/5/2018	Citigroup	Upgrade	Neutral ➝ Buy	$260.00 ➝ $275.00	High
1/31/2018	Leerink Swann	Boost Price Target	Outperform ➝ Outperform	$250.00 ➝ $276.00	High
1/31/2018	Canaccord Genuity	Reiterated Rating	Buy	$255.00 ➝ $265.00	High
1/31/2018	First Analysis	Upgrade	Equal Weight ➝ Overweight	$277.00	High
1/22/2018	Cowen	Boost Price Target	Outperform	$250.00 ➝ $275.00	Low
1/16/2018	Deutsche Bank	Set Price Target	Buy	$275.00	Medium
1/9/2018	Wells Fargo & Co	Reiterated Rating	Outperform ➝ Positive	$250.00 ➝ $260.00	High
1/9/2018	Piper Jaffray Companies	Reiterated Rating	Buy	$269.00	N/A
1/5/2018	William Blair	Downgrade	Outperform ➝ Market Perform		Medium
1/3/2018	Evercore ISI	Initiated Coverage	Outperform	$250.00	Low
10/25/2017	Bank of America	Boost Price Target	Buy	$215.00 ➝ $240.00	N/A
10/23/2017	Janney Montgomery Scott	Upgrade	Sell ➝ Neutral		N/A
9/26/2017	Goldman Sachs Group	Reiterated Rating	Neutral ➝ Neutral	$200.00	Low
9/13/2017	Argus	Boost Price Target	Buy	$205.00 ➝ $235.00	Low
8/2/2017	JPMorgan Chase & Co.	Reiterated Rating	Overweight	$250.00	High
4/26/2017	Cantor Fitzgerald	Boost Price Target	Neutral ➝ Neutral	$155.00 ➝ $170.00	High
2/1/2017	UBS	Boost Price Target	Buy	$180.00 ➝ $185.00	N/A
1/6/2017	CL King	Upgrade	Neutral ➝ Buy		N/A
7/27/2016	Mizuho	Boost Price Target	Neutral	$138.00 ➝ $148.00	N/A

(Data available from 5/26/2016 forward)

Illumina (NASDAQ:ILMN) Earnings History and Estimates Chart

Earnings by Quarter for Illumina (NASDAQ:ILMN)

Illumina (NASDAQ:ILMN) Earnings Estimates

2018 EPS Consensus Estimate: $4.41
2019 EPS Consensus Estimate: $5.48

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	3	$0.88	$1.09	$1.00
Q2 2018	4	$1.07	$1.15	$1.10
Q3 2018	4	$1.10	$1.24	$1.14
Q4 2018	4	$1.16	$1.17	$1.17
Q1 2019	4	$1.19	$1.64	$1.37
Q2 2019	3	$1.20	$1.36	$1.27
Q3 2019	3	$1.35	$1.45	$1.41
Q4 2019	3	$1.36	$1.53	$1.43

Illumina (NASDAQ ILMN) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
7/30/2018		$1.11					N/A
4/24/2018	Q1 2018	$1.02	$1.45	$744.30 million	$782.00 million	View	N/A
1/30/2018	Q4 2017	$1.22	$1.44	$752.04 million	$778.00 million	View	Listen
10/24/2017	Q3 2017	$0.99	$1.11	$692.77 million	$714.00 million	View	N/A
8/1/2017	Q2 2017	$0.68	$0.82	$642.38 million	$662.00 million	View	Listen
4/25/2017	Q1 2017	$0.64	$0.64	$590.51 million	$598.00 million	View	N/A
1/31/2017	Q416	$0.82	$0.85	$612.50 million	$619.00 million	View	Listen
11/1/2016	Q316	$0.87	$0.97	$628.06 million	$607.00 million	View	Listen
7/26/2016	Q2	$0.73	$0.86	$31.91 million	$600.00 million	View	Listen
5/3/2016	Q1	$0.74	$0.71	$596.33 million	$572.00 million	View	Listen
2/2/2016	Q415	$0.82	$0.81	$576.39 million	$591.50 million	View	Listen
10/20/2015	Q315	$0.79	$0.80	$568.60 million	$550.00 million	View	Listen
7/21/2015	Q215	$0.77	$0.80	$541.05 million	$539.00 million	View	Listen
4/21/2015	Q115	$0.72	$0.91	$524.35 million	$539.00 million	View	Listen
1/27/2015	Q414	$0.78	$0.87	$503.83 million	$512.00 million	View	Listen
10/20/2014	Q314	$0.56	$0.77	$451.20 million	$481.00 million	View	Listen
7/23/2014	Q214	$0.51	$0.57	$426.50 million	$448.00 million	View	Listen
4/22/2014	Q114	$0.44	$0.53	$391.50 million	$421.00 million	View	Listen
1/28/2014	Q413	$0.44	$0.45	$382.06 million	$387.00 million	View	Listen
10/21/2013	Q313	$0.40	$0.45	$343.42 million	$357.00 million	View	Listen
7/23/2013	Q2 2013	$0.40	$0.43	$331.77 million	$346.09 million	View	Listen
4/22/2013	Q1 2013	$0.39	$0.46	$310.64 million	$330.96 million	View	Listen
1/28/2013	Q4 2012	$0.41	$0.42	$303.13 million	$309.30 million	View	Listen
10/23/2012		$0.39	$0.41			View	N/A
7/24/2012		$0.36	$0.40			View	N/A
4/23/2012		$0.32	$0.36			View	N/A
2/7/2012		$0.30	$0.35			View	N/A
10/25/2011		$0.23	$0.22			View	N/A
7/26/2011	Q2 2011	$0.36	$0.38			View	N/A
4/26/2011		$0.31	$0.35			View	N/A
2/8/2011		$0.29	$0.29			View	N/A
10/26/2010	Q3 2010	$0.24	$0.30			View	N/A
7/27/2010	Q2 2010	$0.23	$0.26			View	N/A
4/28/2010	Q1 2010	$0.19	$0.21			View	N/A
2/4/2010	Q4 2009	$0.19	$0.20			View	N/A
10/27/2009	Q3 2009	$0.20	$0.17			View	N/A
7/21/2009	Q2 2009	$0.18	$0.18			View	N/A
4/21/2009	Q1 2009	$0.19	$0.19			View	N/A
2/3/2009	Q4 2008	$0.17	$0.24			View	N/A
10/21/2008	Q3 2008	$0.17	$0.17			View	N/A
7/22/2008	Q2 2008	$0.14	$0.15			View	N/A
4/22/2008	Q1 2008	$0.12	$0.12			View	N/A
2/4/2008	Q4 2007	$0.12	$0.15			View	N/A

(Earnings results data provided by Zacks Investment Research)

Illumina (NASDAQ:ILMN) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Illumina (NASDAQ ILMN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.54%
Institutional Ownership Percentage: 90.75%

Insider Trading History for Illumina (NASDAQ:ILMN)

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Illumina (NASDAQ ILMN) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/21/2018	Karin Eastham	Director	Sell	1,000	$269.80	$269,800.00	13,088
5/16/2018	Mostafa Ronaghi	SVP	Sell	10,000	$267.71	$2,677,100.00	80,996
5/14/2018	Francis A Desouza	CEO	Sell	2,100	$268.63	$564,123.00	87,371
5/14/2018	Jay T. Flatley	Director	Sell	1,460	$268.00	$391,280.00
5/2/2018	Omead Ostadan	EVP	Sell	1,314	$242.60	$318,776.40	27,153
5/1/2018	A Blaine Bowman	Director	Sell	3,000	$241.45	$724,350.00	18,668
4/12/2018	Oene Mark Van	SVP	Sell	1,400	$238.48	$333,872.00	12,217
4/3/2018	Charles Dadswell	SVP	Sell	116	$230.91	$26,785.56	7,875
4/2/2018	A Blaine Bowman	Director	Sell	3,000	$230.13	$690,390.00	19,868
3/15/2018	Frances Arnold	Director	Sell	250	$252.26	$63,065.00	10,189
3/8/2018	Frances Arnold	Director	Sell	250	$241.50	$60,375.00	10,439
3/5/2018	Charles Dadswell	SVP	Sell	145	$227.17	$32,939.65	7,991
3/5/2018	Karin Eastham	Director	Sell	2,000	$229.37	$458,740.00	15,288
3/2/2018	Omead Ostadan	EVP	Sell	1,329	$222.66	$295,915.14	29,392
2/28/2018	Robert S Epstein	Director	Sell	250	$231.25	$57,812.50	7,088
2/16/2018	Oene Mark Van	SVP	Sell	1,408	$228.85	$322,220.80	15,760
2/6/2018	Marc Stapley	EVP	Sell	2,000	$216.87	$433,740.00	27,952
2/5/2018	Charles Dadswell	SVP	Sell	1,610	$221.45	$356,534.50	5,581
2/1/2018	A Blaine Bowman	Director	Sell	3,000	$230.82	$692,460.00	19,868
1/29/2018	Robert S Epstein	Director	Sell	1,250	$244.18	$305,225.00	8,588
1/17/2018	Marc Stapley	EVP	Sell	2,000	$242.33	$484,660.00	29,815
1/16/2018	Jay T Flatley	Director	Sell	15,000	$243.72	$3,655,800.00	449,201
1/3/2018	Charles Dadswell	SVP	Sell	145	$224.50	$32,552.50	7,411
1/2/2018	Jay T Flatley	Director	Sell	20,000	$223.40	$4,468,000.00	463,436
12/29/2017	Robert S Epstein	Director	Sell	1,250	$217.38	$271,725.00
12/29/2017	Robert S Epstein	Director	Sell	1,250	$217.38	$271,725.00	8,838
12/19/2017	Jay T Flatley	Director	Sell	20,000	$215.48	$4,309,600.00	480,476
12/5/2017	Jay T Flatley	Director	Sell	20,000	$212.55	$4,251,000.00	505,980
12/4/2017	Charles Dadswell	SVP	Sell	145	$225.33	$32,672.85	6,388
12/4/2017	Marc Stapley	EVP	Sell	2,000	$219.88	$439,760.00	29,198
12/1/2017	Omead Ostadan	EVP	Sell	3,540	$226.91	$803,261.40	26,827
12/1/2017	Robert S Epstein	Director	Sell	1,250	$226.55	$283,187.50	9,088
11/21/2017	Jay T Flatley	Director	Sell	20,000	$211.35	$4,227,000.00	531,717
11/15/2017	Marc Stapley	EVP	Sell	2,000	$205.48	$410,960.00	30,370
11/15/2017	Oene Mark Van	SVP	Sell	1,250	$207.76	$259,700.00	11,691
11/13/2017	Oene Mark Van	SVP	Sell	1,232	$207.78	$255,984.96	11,691
11/7/2017	Jay T Flatley	Director	Sell	20,000	$210.59	$4,211,800.00	536,717
11/3/2017	Charles Dadswell	SVP	Sell	1,609	$207.88	$334,478.92	7,217
10/26/2017	Marc Stapley	EVP	Sell	2,000	$206.88	$413,760.00	34,579
10/24/2017	Jay T Flatley	Director	Sell	20,000	$210.43	$4,208,600.00	539,176
10/12/2017	Oene Mark Van	SVP	Sell	1,250	$207.21	$259,012.50
10/10/2017	Jay T Flatley	Director	Sell	20,000	$203.27	$4,065,400.00
10/3/2017	Charles Dadswell	SVP	Sell	145	$202.23	$29,323.35
9/26/2017	Jay T Flatley	Director	Sell	20,000	$200.16	$4,003,200.00	539,176
9/12/2017	Jay T Flatley	Director	Sell	20,000	$211.11	$4,222,200.00	539,176
9/12/2017	Oene Mark Van	SVP	Sell	9,729	$211.33	$2,056,029.57	24,908
9/7/2017	Mostafa Ronaghi	SVP	Sell	20,000	$210.00	$4,200,000.00	86,725
9/5/2017	Charles Dadswell	SVP	Sell	145	$205.71	$29,827.95
9/5/2017	Marc Stapley	EVP	Sell	2,000	$205.93	$411,860.00	36,179
8/31/2017	Michel Bouchard	Insider	Sell	5,390	$202.11	$1,089,372.90	15,161
8/30/2017	Michel Bouchard	CAO	Sell	616	$200.00	$123,200.00	15,161
8/29/2017	Jay T Flatley	Director	Sell	22,540	$195.21	$4,400,033.40	539,176
8/28/2017	Jay T Flatley	Director	Sell	2,540	$197.39	$501,370.60	539,176
8/15/2017	Jay T Flatley	Director	Sell	20,000	$194.73	$3,894,600.00	539,176
8/7/2017	Omead Ostadan	EVP	Sell	1,671	$195.26	$326,279.46	24,571
8/3/2017	Charles Dadswell	SVP	Sell	1,609	$197.00	$316,973.00	9,037
8/3/2017	Marc Stapley	EVP	Sell	2,000	$196.80	$393,600.00	37,941
8/2/2017	Jay T Flatley	Director	Sell	20,000	$176.43	$3,528,600.00	534,176
8/2/2017	Michel Bouchard	Insider	Sell	3,131	$194.97	$610,451.07	15,777
8/2/2017	Mostafa Ronaghi	SVP	Sell	10,000	$195.00	$1,950,000.00	76,585
7/18/2017	Jay T Flatley	Director	Sell	15,000	$170.77	$2,561,550.00	534,176
7/14/2017	Marc Stapley	EVP	Sell	2,000	$173.56	$347,120.00	39,941
7/7/2017	Omead Ostadan	EVP	Sell	1,672	$172.73	$288,804.56	26,242
7/5/2017	Jay T Flatley	Director	Sell	15,000	$172.92	$2,593,800.00	534,176
7/3/2017	Charles Dadswell	SVP	Sell	145	$174.24	$25,264.80	10,646
6/23/2017	Michel Bouchard	Insider	Sell	246	$185.00	$45,510.00	18,893
6/22/2017	Jay T Flatley	Director	Sell	20,000	$178.21	$3,564,200.00	534,176
6/12/2017	Marc Stapley	EVP	Sell	2,000	$170.85	$341,700.00	41,341
6/8/2017	Michel Bouchard	Insider	Sell	246	$178.91	$44,011.86	19,139
6/6/2017	Jay T Flatley	Director	Sell	20,000	$180.24	$3,604,800.00	539,176
6/5/2017	Charles Dadswell	SVP	Sell	145	$184.75	$26,788.75	10,791
6/1/2017	Jay T Flatley	Director	Sell	3,320	$180.55	$599,426.00	519,176
5/25/2017	Frances Arnold	Director	Sell	825	$174.77	$144,185.25	8,816
5/23/2017	Jay T Flatley	Director	Sell	15,000	$175.53	$2,632,950.00	534,176
5/10/2017	A Blaine Bowman	Director	Sell	2,300	$181.61	$417,703.00	18,004
5/9/2017	Jay T Flatley	Director	Sell	20,000	$184.14	$3,682,800.00	539,176
5/9/2017	Michel Bouchard	Insider	Sell	5,740	$184.68	$1,060,063.20	22,255
5/3/2017	Charles Dadswell	SVP	Sell	1,609	$187.07	$300,995.63	10,936
4/12/2017	A Blaine Bowman	Director	Sell	3,000	$172.72	$518,160.00	18,704
4/7/2017	Daniel Bradbury	Director	Sell	600	$172.79	$103,674.00	17,065
3/24/2017	Omead Ostadan	EVP	Sell	1,672	$170.00	$284,240.00	29,586
3/21/2017	Daniel Bradbury	Director	Sell	600	$163.56	$98,136.00	17,065
2/17/2017	Daniel Bradbury	Director	Sell	600	$162.80	$97,680.00	17,065
2/13/2017	Omead Ostadan	EVP	Sell	2,173	$163.10	$354,416.30
2/8/2017	A Blaine Bowman	Director	Sell	3,000	$162.74	$488,220.00	16,204
2/6/2017	Charles Dadswell	SVP	Sell	572	$161.26	$92,240.72	7,592
1/30/2017	Omead Ostadan	EVP	Sell	259	$160.90	$41,673.10	27,949
1/19/2017	Omead Ostadan	EVP	Sell	2,378	$160.06	$380,622.68	29,040
1/11/2017	A Blaine Bowman	Director	Sell	3,000	$162.89	$488,670.00	18,704
1/10/2017	Charles Dadswell	SVP	Sell	116	$161.60	$18,745.60
1/4/2017	Daniel Bradbury	Director	Sell	600	$135.01	$81,006.00	17,065
12/15/2016	Omead Ostadan	EVP	Sell	2,000	$126.16	$252,320.00
12/12/2016	Daniel Bradbury	Director	Sell	600	$123.42	$74,052.00	17,065
12/8/2016	Omead Ostadan	EVP	Sell	3,000	$121.63	$364,890.00	52,988
12/1/2016	Omead Ostadan	EVP	Sell	3,000	$133.30	$399,900.00	51,492
11/14/2016	Daniel Bradbury	Director	Sell	600	$136.34	$81,804.00	17,065
10/7/2016	Daniel Bradbury	Director	Sell	600	$184.36	$110,616.00	17,065
10/4/2016	Charles Dadswell	SVP	Sell	116	$182.38	$21,156.08	39,900
9/20/2016	Robert S Epstein	Director	Sell	300	$174.29	$52,287.00	6,924
9/15/2016	Marc Stapley	EVP	Sell	1,270	$172.87	$219,544.90	33,916
9/14/2016	Daniel Bradbury	Director	Sell	600	$171.25	$102,750.00	17,065
8/23/2016	Jay T Flatley	Director	Sell	20,000	$172.99	$3,459,800.00	508,061
8/22/2016	Robert S Epstein	Director	Sell	300	$170.27	$51,081.00	7,224
8/17/2016	Daniel Bradbury	Director	Sell	600	$168.42	$101,052.00	17,065
8/15/2016	Jay T Flatley	Director	Sell	10,000	$170.00	$1,700,000.00	498,061
8/12/2016	Roy A Whitfield	Director	Sell	4,000	$167.22	$668,880.00	6,853
8/9/2016	Jay T Flatley	Director	Sell	10,000	$165.97	$1,659,700.00	498,061
8/1/2016	Jay T Flatley	Director	Sell	10,000	$170.00	$1,700,000.00	498,061
7/27/2016	Charles Dadswell	SVP	Sell	8,632	$155.00	$1,337,960.00	40,248
7/26/2016	Jay T Flatley	Director	Sell	10,000	$150.00	$1,500,000.00	498,061
7/20/2016	Robert S Epstein	Director	Sell	1,200	$150.00	$180,000.00	7,824
7/18/2016	Jay T Flatley	Director	Sell	10,000	$150.00	$1,500,000.00	498,061
7/14/2016	A Blaine Bowman	Director	Sell	5,000	$147.14	$735,700.00	20,704
7/11/2016	Christian O Henry	EVP	Sell	716	$141.89	$101,593.24	18,976
6/16/2016	A Blaine Bowman	Director	Sell	5,000	$135.08	$675,400.00	20,704
6/15/2016	Christian O Henry	EVP	Sell	2,141	$137.90	$295,243.90	20,213
6/13/2016	Roy A Whitfield	Director	Sell	3,800	$140.44	$533,672.00	6,653
6/1/2016	Karin Eastham	Director	Sell	5,000	$145.35	$726,750.00	17,424
5/25/2016	Christian O Henry	EVP	Sell	2,141	$144.73	$309,866.93	22,463
5/17/2016	Christian O Henry	EVP	Sell	2,141	$140.84	$301,538.44	24,174
5/12/2016	A Blaine Bowman	Director	Sell	5,000	$137.11	$685,550.00	18,615
4/27/2016	Christian O Henry	EVP	Sell	2,141	$138.46	$296,442.86	27,073
4/18/2016	Christian O Henry	EVP	Sell	2,141	$176.01	$376,837.41	29,889
4/18/2016	Paul L Bianchi	VP	Sell	1,884	$175.00	$329,700.00	65,660
4/14/2016	A Blaine Bowman	Director	Sell	5,000	$172.94	$864,700.00	18,615
4/13/2016	Christian O Henry	EVP	Sell	12,500	$175.00	$2,187,500.00	42,897
4/13/2016	Paul L Bianchi	VP	Sell	6,681	$175.00	$1,169,175.00	67,544
4/12/2016	Jay T Flatley	CEO	Sell	20,000	$170.05	$3,401,000.00	508,061
4/12/2016	Roy A Whitfield	Director	Sell	4,000	$170.00	$680,000.00	5,800
4/7/2016	David R Walt	Director	Sell	4,000	$168.90	$675,600.00	635,840
4/5/2016	Christian O Henry	EVP	Sell	2,141	$166.07	$355,555.87	31,997
4/4/2016	Charles Dadswell	SVP	Sell	8,382	$167.81	$1,406,583.42	54,970
3/23/2016	Christian O Henry	EVP	Sell	2,141	$155.05	$331,962.05	33,738
3/22/2016	Jay T Flatley	CEO	Sell	10,000	$154.18	$1,541,800.00	498,061
3/21/2016	Daniel Bradbury	Director	Sell	1,200	$155.63	$186,756.00	15,576
3/21/2016	Nicholas Naclerio	SVP	Sell	4,520	$154.25	$697,210.00	30,020
3/17/2016	A Blaine Bowman	Director	Sell	5,000	$145.24	$726,200.00	18,615
3/15/2016	David R Walt	Director	Sell	4,000	$149.99	$599,960.00	635,840
3/14/2016	Christian O Henry	EVP	Sell	5,892	$155.91	$918,621.72	38,529
3/8/2016	Charles Dadswell	SVP	Sell	8,382	$155.63	$1,304,490.66	66,507
3/8/2016	Jay T Flatley	CEO	Sell	10,000	$154.49	$1,544,900.00	500,915
3/8/2016	Omead Ostadan	EVP	Sell	4,516	$156.09	$704,902.44	60,576
3/7/2016	Charles Dadswell	SVP	Sell	116	$155.00	$17,980.00	66,507
2/23/2016	Jay T Flatley	CEO	Sell	10,000	$152.49	$1,524,900.00	440,784
2/17/2016	Daniel Bradbury	Director	Sell	1,700	$154.74	$263,058.00	14,376
2/12/2016	Roy A. Whitfield	Director	Sell	3,750	$140.30	$526,125.00	1,800
2/1/2016	Omead Ostadan	EVP	Sell	1,108	$156.73	$173,656.84	46,476
1/26/2016	Jay T. Flatley	CEO	Sell	20,000	$171.70	$3,434,000.00	433,423
1/13/2016	Jay T. Flatley	CEO	Sell	20,000	$168.81	$3,376,200.00	433,423
1/4/2016	Daniel Bradbury	Director	Sell	1,700	$182.80	$310,760.00	14,376
12/28/2015	Charles Dadswell	SVP	Sell	168	$188.63	$31,689.84	41,830
12/22/2015	Jay T. Flatley	CEO	Sell	25,000	$185.38	$4,634,500.00	433,423
12/14/2015	Roy A. Whitfield	Director	Sell	3,750	$175.07	$656,512.50	13,648
12/11/2015	Omead Ostadan	EVP	Sell	260	$179.90	$46,774.00	48,293
12/11/2015	Paul L Bianchi	VP	Sell	197	$179.90	$35,440.30	59,827
12/10/2015	Daniel Bradbury	Director	Sell	1,700	$182.37	$310,029.00	14,376
12/8/2015	Jay T. Flatley	CEO	Sell	25,000	$177.11	$4,427,750.00	433,423
11/27/2015	Robert S Epstein	Director	Sell	1,000	$185.56	$185,560.00	6,935
11/25/2015	Jay T. Flatley	CEO	Sell	5,000	$180.00	$900,000.00	423,793
11/24/2015	Jay T. Flatley	CEO	Sell	20,000	$173.27	$3,465,400.00	423,793
11/16/2015	Jay T. Flatley	CEO	Sell	10,000	$170.00	$1,700,000.00	423,793
11/10/2015	Daniel Bradbury	Director	Sell	1,700	$154.03	$261,851.00	14,376
11/10/2015	Jay T. Flatley	CEO	Sell	10,000	$154.58	$1,545,800.00	423,793
11/3/2015	Charles Dadswell	SVP	Sell	158	$150.00	$23,700.00	40,847
10/15/2015	Jay T. Flatley	CEO	Sell	10,000	$150.00	$1,500,000.00	424,996
10/7/2015	Daniel Bradbury	Director	Sell	1,700	$145.81	$247,877.00	14,376
9/29/2015	David R Walt	Director	Sell	2,000	$171.65	$343,300.00	648,840
9/22/2015	Jay T. Flatley	CEO	Sell	25,000	$192.79	$4,819,750.00	424,996
9/15/2015	David R Walt	Director	Sell	2,000	$206.45	$412,900.00	648,840
9/14/2015	Daniel Bradbury	Director	Sell	1,700	$203.89	$346,613.00	14,376
9/9/2015	Paul L. Bianchi	VP	Sell	1,245	$199.32	$248,153.40	58,519
9/8/2015	Jay T. Flatley	CEO	Sell	25,000	$194.87	$4,871,750.00	424,996
9/8/2015	Karin Eastham	Director	Sell	4,300	$195.76	$841,768.00	10,419
9/4/2015	Roy A. Whitfield	Director	Sell	4,500	$192.63	$866,835.00	13,648
9/1/2015	David R Walt	Director	Sell	2,000	$195.08	$390,160.00	648,840
8/27/2015	Jay T. Flatley	CEO	Sell	25,000	$200.16	$5,004,000.00	424,996
8/18/2015	David R Walt	Director	Sell	2,000	$206.89	$413,780.00
8/17/2015	Daniel Bradbury	Director	Sell	1,700	$208.14	$353,838.00
8/13/2015	Jay T Flatley	CEO	Sell	25,000	$207.85	$5,196,250.00
8/5/2015	Roy A. Whitfield	Director	Sell	4,500	$215.22	$968,490.00	13,648
7/24/2015	A Blaine Bowman	Director	Sell	3,000	$221.47	$664,410.00
7/23/2015	Jay T Flatley	CEO	Sell	25,000	$214.87	$5,371,750.00
7/21/2015	David R Walt	Director	Sell	12,000	$235.24	$2,822,880.00
7/17/2015	Mostafa Ronaghi	SVP	Sell	1,200	$235.00	$282,000.00
7/16/2015	Christian O Henry	SVP	Sell	5,390	$229.61	$1,237,597.90
7/15/2015	Mostafa Ronaghi	SVP	Sell	3,000	$227.19	$681,570.00
7/14/2015	David R Walt	Director	Sell	10,000	$227.39	$2,273,900.00
7/13/2015	Marc Stapley	CFO	Sell	3,000	$214.90	$644,700.00
7/13/2015	Michel Bouchard	CAO	Sell	1,400	$222.75	$311,850.00
7/10/2015	Omead Ostadan	SVP	Sell	1,110	$219.81	$243,989.10
7/10/2015	Robert S Epstein	Director	Sell	2,000	$219.81	$439,620.00
7/9/2015	Jay T Flatley	CEO	Sell	25,000	$218.10	$5,452,500.00
7/7/2015	David R Walt	Director	Sell	10,000	$220.22	$2,202,200.00
7/6/2015	Daniel Bradbury	Director	Sell	1,700	$219.70	$373,490.00
6/30/2015	David R Walt	Director	Sell	10,000	$217.64	$2,176,400.00
6/25/2015	Jay T Flatley	CEO	Sell	25,000	$220.34	$5,508,500.00
6/24/2015	A Blaine Bowman	Director	Sell	3,000	$221.43	$664,290.00
6/24/2015	Christian O Henry	SVP	Sell	5,084	$221.07	$1,123,919.88
6/23/2015	David R Walt	Director	Sell	12,000	$220.11	$2,641,320.00
6/17/2015	Christian O Henry	SVP	Sell	3,751	$215.71	$809,128.21
6/16/2015	David R Walt	Director	Sell	10,000	$215.14	$2,151,400.00
6/15/2015	Nicholas Naclerio	SVP	Sell	6,590	$214.33	$1,412,434.70
6/15/2015	Paul L Bianchi	VP	Sell	3,408	$215.83	$735,548.64
6/12/2015	Marc Stapley	CFO	Sell	3,000	$214.90	$644,700.00
6/12/2015	Michel Bouchard	CAO	Sell	1,400	$216.11	$302,554.00
6/11/2015	Jay T Flatley	CEO	Sell	25,000	$216.41	$5,410,250.00
6/10/2015	Christian O Henry	SVP	Sell	10,000	$214.94	$2,149,400.00
6/10/2015	Robert S Epstein	Director	Sell	2,000	$214.24	$428,480.00
6/5/2015	Roy A Whitfield	Director	Sell	4,500	$207.49	$933,705.00
6/2/2015	David R Walt	Director	Sell	10,000	$204.42	$2,044,200.00
6/1/2015	Karin Eastham	Director	Sell	5,000	$205.24	$1,026,200.00
5/29/2015	Daniel Bradbury	Director	Sell	1,700	$206.62	$351,254.00
5/28/2015	Jay T Flatley	CEO	Sell	25,000	$208.78	$5,219,500.00
5/22/2015	A Blaine Bowman	Director	Sell	3,000	$204.58	$613,740.00
5/19/2015	David R Walt	Director	Sell	10,000	$202.00	$2,020,000.00
5/14/2015	Christian O Henry	SVP	Sell	3,751	$198.52	$744,648.52
5/14/2015	Jay T Flatley	CEO	Sell	25,000	$197.76	$4,944,000.00
5/13/2015	Paul L Bianchi	VP	Sell	3,356	$197.14	$661,601.84
5/11/2015	Robert S Epstein	Director	Sell	2,000	$196.49	$392,980.00
4/28/2015	David R Walt	Director	Sell	7,000	$183.88	$1,287,160.00
4/24/2015	A Blaine Bowman	Director	Sell	3,000	$190.73	$572,190.00
4/23/2015	Jay T Flatley	CEO	Sell	25,000	$189.57	$4,739,250.00
4/21/2015	David R Walt	Director	Sell	10,000	$197.95	$1,979,500.00
4/15/2015	Christian O Henry	SVP	Sell	3,751	$189.02	$709,014.02
4/14/2015	David R Walt	Director	Sell	7,000	$188.23	$1,317,610.00
4/13/2015	Marc Stapley	CFO	Sell	3,000	$190.12	$570,360.00
4/13/2015	Michel Bouchard	CAO	Sell	1,400	$188.61	$264,054.00
4/13/2015	Paul L Bianchi	VP	Sell	3,390	$187.22	$634,675.80
4/10/2015	Robert S Epstein	Director	Sell	2,000	$186.99	$373,980.00
4/9/2015	Jay T Flatley	CEO	Sell	25,000	$184.55	$4,613,750.00
4/8/2015	Daniel Bradbury	Director	Sell	1,700	$185.32	$315,044.00
4/7/2015	David R Walt	Director	Sell	5,000	$184.28	$921,400.00
4/6/2015	Roy A Whitfield	Director	Sell	4,600	$181.32	$834,072.00
3/26/2015	Jay T Flatley	CEO	Sell	25,000	$181.34	$4,533,500.00
3/24/2015	David R Walt	Director	Sell	5,000	$192.16	$960,800.00
3/17/2015	A Blaine Bowman	Director	Sell	3,000	$192.30	$576,900.00
3/16/2015	Gerald Moeller	Director	Sell	2,700	$193.36	$522,072.00
3/16/2015	Nicholas Naclerio	SVP	Sell	6,590	$193.94	$1,278,064.60
3/13/2015	Paul L Bianchi	VP	Sell	3,390	$186.67	$632,811.30
3/12/2015	Marc Stapley	CFO	Sell	3,314	$189.01	$626,379.14
3/10/2015	Richard Klausner	SVP	Sell	1,186	$191.75	$227,415.50
3/10/2015	Robert S Epstein	Director	Sell	3,000	$191.75	$575,250.00
2/26/2015	Jay T Flatley	CEO	Sell	25,000	$195.73	$4,893,250.00
2/12/2015	Jay T Flatley	CEO	Sell	25,000	$194.64	$4,866,000.00
2/3/2015	David R Walt	Director	Sell	7,000	$190.89	$1,336,230.00
2/2/2015	Karin Eastham	Director	Sell	10,000	$192.77	$1,927,700.00
2/2/2015	Nicholas Naclerio	SVP	Sell	15,250	$194.37	$2,964,142.50
1/27/2015	Charles Dadswell	SVP	Sell	224	$198.90	$44,553.60
1/27/2015	David R Walt	Director	Sell	4,000	$201.76	$807,040.00
1/22/2015	Jay T Flatley	CEO	Sell	25,000	$188.48	$4,712,000.00
1/20/2015	William H Rastetter	Director	Sell	16,000	$188.99	$3,023,840.00
1/15/2015	Marc Stapley	CFO	Sell	1,422	$181.62	$258,263.64
1/8/2015	Jay T Flatley	CEO	Sell	25,000	$197.62	$4,940,500.00
1/6/2015	David R Walt	Director	Sell	6,000	$188.55	$1,131,300.00
1/2/2015	Karin Eastham	Director	Sell	10,000	$185.63	$1,856,300.00
12/30/2014	David R Walt	Director	Sell	5,000	$186.95	$934,750.00
12/29/2014	Gerald Moeller	Director	Sell	8,000	$187.05	$1,496,400.00
12/26/2014	Jay T Flatley	CEO	Sell	25,000	$186.71	$4,667,750.00
12/23/2014	David R Walt	Director	Sell	7,000	$184.55	$1,291,850.00
12/16/2014	David R Walt	Director	Sell	5,000	$178.35	$891,750.00
12/15/2014	Marc Stapley	CFO	Sell	1,422	$181.09	$257,509.98
12/11/2014	Jay T Flatley	CEO	Sell	25,000	$185.79	$4,644,750.00
12/9/2014	David R Walt	Director	Sell	7,000	$186.75	$1,307,250.00
12/8/2014	Daniel Bradbury	Director	Sell	1,600	$190.14	$304,224.00
12/4/2014	Karin Eastham	Director	Sell	10,000	$191.87	$1,918,700.00
12/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$188.46	$1,884,600.00
11/26/2014	Paul L Bianchi	SVP	Sell	1,626	$189.20	$307,639.20
11/17/2014	Roy A Whitfield	Director	Sell	4,000	$178.26	$713,040.00
11/14/2014	Marc Stapley	CFO	Sell	1,422	$181.13	$257,566.86
11/13/2014	Daniel Bradbury	Director	Sell	2,100	$186.88	$392,448.00
11/13/2014	Jay T Flatley	CEO	Sell	25,000	$189.32	$4,733,000.00
11/3/2014	Michel Bouchard	CAO	Sell	631	$195.68	$123,474.08
11/3/2014	Mostafa Ronaghi	SVP	Sell	10,000	$195.66	$1,956,600.00
10/30/2014	Daniel Bradbury	Director	Sell	2,100	$191.83	$402,843.00
10/23/2014	Jay T Flatley	CEO	Sell	25,000	$189.54	$4,738,500.00
10/13/2014	Daniel Bradbury	Director	Sell	2,100	$152.03	$319,263.00
10/9/2014	Jay T Flatley	CEO	Sell	25,000	$163.49	$4,087,250.00
10/7/2014	A Blaine Bowman	Director	Sell	4,456	$159.51	$710,776.56
10/1/2014	Daniel Bradbury	Director	Sell	2,100	$158.88	$333,648.00
10/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$159.81	$1,598,100.00
9/30/2014	A Blaine Bowman	Director	Sell	5,000	$164.02	$820,100.00
9/29/2014	Gerald Moeller	Director	Sell	5,000	$164.89	$824,450.00
9/25/2014	Jay T Flatley	CEO	Sell	25,000	$164.43	$4,110,750.00
9/24/2014	Christian O Henry	SVP	Sell	20,000	$167.28	$3,345,600.00
9/23/2014	A Blaine Bowman	Director	Sell	5,000	$168.50	$842,500.00
9/16/2014	A Blaine Bowman	Director	Sell	5,000	$169.60	$848,000.00
9/15/2014	Daniel Bradbury	Director	Sell	2,100	$168.57	$353,997.00
9/15/2014	Jay T Flatley	CEO	Sell	25,000	$176.06	$4,401,500.00
9/15/2014	Marc Stapley	CFO	Sell	1,422	$169.05	$240,389.10
9/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$169.53	$339,060.00
9/9/2014	A Blaine Bowman	Director	Sell	5,000	$178.08	$890,400.00
9/3/2014	Christian O Henry	SVP	Sell	10,000	$180.59	$1,805,900.00
9/3/2014	Daniel Bradbury	Director	Sell	2,100	$179.77	$377,517.00
9/2/2014	A Blaine Bowman	Director	Sell	5,000	$179.67	$898,350.00
9/2/2014	Michel Bouchard	VP	Sell	686	$180.07	$123,528.02
9/2/2014	Mostafa Ronaghi	SVP	Sell	10,000	$179.66	$1,796,600.00
8/28/2014	Jay T Flatley	CEO	Sell	30,000	$178.98	$5,369,400.00
8/26/2014	A Blaine Bowman	Director	Sell	5,000	$179.22	$896,100.00
8/22/2014	Daniel Bradbury	Director	Sell	2,100	$172.24	$361,704.00
8/19/2014	A Blaine Bowman	Director	Sell	5,000	$171.70	$858,500.00
8/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$167.23	$334,460.00
8/15/2014	Roy A Whitfield	Director	Sell	4,000	$169.28	$677,120.00
8/13/2014	Christian O Henry	SVP	Sell	20,000	$164.66	$3,293,200.00
8/5/2014	A Blaine Bowman	Director	Sell	5,000	$159.91	$799,550.00
8/4/2014	Daniel Bradbury	Director	Sell	2,100	$159.77	$335,517.00
8/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$159.73	$1,597,300.00
7/29/2014	A Blaine Bowman	Director	Sell	5,000	$166.89	$834,450.00
7/29/2014	Christian O Henry	SVP	Sell	10,000	$167.40	$1,674,000.00
7/24/2014	Jay T Flatley	CEO	Sell	30,000	$175.43	$5,262,900.00
7/23/2014	Daniel Bradbury	Director	Sell	2,100	$177.87	$373,527.00
7/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$174.26	$348,520.00
7/14/2014	Marc Stapley	CFO	Sell	1,422	$177.59	$252,532.98
7/10/2014	Jay T Flatley	CEO	Sell	30,000	$172.56	$5,176,800.00
7/8/2014	Daniel Bradbury	Director	Sell	2,100	$172.89	$363,069.00
7/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$179.47	$1,794,700.00
6/30/2014	Gerald Moeller	Director	Sell	5,000	$178.97	$894,850.00
6/27/2014	Daniel Bradbury	Director	Sell	2,100	$171.65	$360,465.00
6/26/2014	Jay T Flatley	CEO	Sell	30,000	$170.11	$5,103,300.00
6/24/2014	Christian O Henry	SVP	Sell	10,000	$172.60	$1,726,000.00
6/16/2014	Christian O Henry	SVP	Sell	20,000	$169.73	$3,394,600.00
6/16/2014	Marc Stapley	CFO	Sell	1,422	$169.25	$240,673.50
6/12/2014	Daniel Bradbury	Director	Sell	2,100	$171.17	$359,457.00
6/12/2014	Jay T Flatley	CEO	Sell	30,000	$172.25	$5,167,500.00
6/2/2014	Karin Eastham	Director	Sell	6,000	$157.56	$945,360.00
6/2/2014	Michel Bouchard	CAO	Sell	1,491	$155.51	$231,865.41
6/2/2014	Mostafa Ronaghi	SVP	Sell	10,000	$156.93	$1,569,300.00
5/22/2014	Jay Flatley	CEO	Sell	30,000	$154.95	$4,648,500.00	381,262
5/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$141.72	$283,440.00	23,146
5/15/2014	Roy Whitfield	Director	Sell	4,000	$143.71	$574,840.00	9,196
5/14/2014	Daniel Bradbury	Director	Sell	2,100	$146.46	$307,566.00	9,924
5/14/2014	Marc Stapley	CFO	Sell	1,422	$146.94	$208,948.68	21,996
5/8/2014	Jay Flatley	CEO	Sell	30,000	$143.59	$4,307,700.00	381,262
5/2/2014	Daniel Bradbury	Director	Sell	2,100	$139.66	$293,286.00	9,924
5/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$135.91	$1,359,100.00	28,604
4/24/2014	Jay Flatley	CEO	Sell	30,000	$150.80	$4,524,000.00	381,262
4/15/2014	Daniel Bradbury	Director	Sell	2,100	$131.29	$275,709.00	9,924
4/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$133.56	$267,120.00	23,146
4/14/2014	Marc Stapley	CFO	Sell	1,422	$134.80	$191,685.60	21,996
4/10/2014	Jay Flatley	CEO	Sell	30,000	$139.90	$4,197,000.00	381,262
4/4/2014	Daniel Bradbury	Director	Sell	2,100	$138.44	$290,724.00	9,924
4/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$152.41	$1,524,100.00	28,604
3/27/2014	Jay Flatley	CEO	Sell	30,000	$140.11	$4,203,300.00	381,262
3/19/2014	Daniel Bradbury	Director	Sell	2,100	$161.14	$338,394.00	9,924
3/17/2014	Gerald Moeller	Director	Sell	10,000	$161.92	$1,619,200.00	14,620
3/17/2014	Nicholas Naclerio	SVP	Sell	2,000	$163.65	$327,300.00	23,146
3/14/2014	Marc Stapley	CFO	Sell	1,422	$163.35	$232,283.70	21,996
3/13/2014	Jay Flatley	CEO	Sell	30,000	$165.96	$4,978,800.00	381,262
3/11/2014	Christian Henry	SVP	Sell	3,000	$167.16	$501,480.00	28,519
3/11/2014	Michel Bouchard	CAO	Sell	2,168	$167.21	$362,511.28	25,049
3/3/2014	Michel Bouchard	CAO	Sell	2,994	$176.81	$529,369.14	29,580
2/25/2014	Michel Bouchard	CAO	Sell	24,505	$176.13	$4,316,065.65	29,580
2/24/2014	Roy Whitfield	Director	Sell	2,000	$175.26	$350,520.00	9,196
2/18/2014	Nicholas Naclerio	SVP	Sell	2,000	$169.77	$339,540.00	25,781
2/13/2014	Jay Flatley	CEO	Sell	30,000	$160.43	$4,812,900.00	385,105
2/7/2014	Jay Flatley	CEO	Sell	5,000	$152.23	$761,150.00	398,105
1/31/2014	Marc Stapley	CFO	Sell	20,038	$151.32	$3,032,150.16	21,797
1/23/2014	Jay Flatley	CEO	Sell	30,000	$142.30	$4,269,000.00	399,509
1/9/2014	Jay Flatley	CEO	Sell	30,000	$114.77	$3,443,100.00	399,509
12/26/2013	Jay Flatley	CEO	Sell	30,000	$107.88	$3,236,400.00	399,509
12/17/2013	Gregory Heath	SVP	Sell	1,875	$102.68	$192,525.00	26,740
10/30/2013	Christian O Henry	SVP	Sell	6,000	$93.29	$559,740.00
10/30/2013	David R Walt	Director	Sell	5,000	$93.02	$465,100.00
10/28/2013	William H Rastetter	Director	Sell	20,000	$92.37	$1,847,400.00
10/24/2013	Jay T Flatley	CEO	Sell	30,000	$92.32	$2,769,600.00
10/22/2013	Nicholas Naclerio	SVP	Sell	20,000	$90.00	$1,800,000.00
10/17/2013	Gregory Heath	SVP	Sell	1,875	$82.09	$153,918.75
10/16/2013	David R Walt	Director	Sell	5,000	$82.59	$412,950.00
10/15/2013	Nicholas Naclerio	SVP	Sell	4,000	$81.32	$325,280.00
10/10/2013	Christian Henry	SVP	Sell	6,000	$77.73	$466,380.00	30,236
10/10/2013	Jay Flatley	CEO	Sell	20,000	$77.75	$1,555,000.00	399,509
10/2/2013	David R Walt	Director	Sell	5,000	$80.58	$402,900.00
9/18/2013	David Walt	Director	Sell	5,000	$83.11	$415,550.00	926,488
9/17/2013	Gregory Heath	SVP	Sell	1,875	$85.20	$159,750.00	26,740
9/16/2013	Jay Flatley	CEO	Sell	30,000	$83.27	$2,498,100.00	399,509
9/16/2013	Nicholas Naclerio	SVP	Sell	4,000	$85.00	$340,000.00	24,559
9/10/2013	Gregory Heath	SVP	Sell	1,875	$82.00	$153,750.00
9/9/2013	Paul L Bianchi	SVP	Sell	1,627	$79.03	$128,581.81
9/5/2013	Christian O Henry	SVP	Sell	9,000	$78.17	$703,530.00
9/4/2013	David R Walt	Director	Sell	5,000	$77.18	$385,900.00
9/3/2013	Nicholas Naclerio	SVP	Sell	59,000	$76.91	$4,537,690.00
9/3/2013	Roy A Whitfield	Director	Sell	2,000	$78.49	$156,980.00
8/30/2013	Mark Lewis	SVP	Sell	5,000	$78.12	$390,600.00	44,837
8/22/2013	Jay Flatley	CEO	Sell	20,000	$78.65	$1,573,000.00	399,509
8/21/2013	David Walt	Director	Sell	5,000	$78.34	$391,700.00	936,488
8/15/2013	Nicholas Naclerio	SVP	Sell	2,000	$78.43	$156,860.00	24,559
8/8/2013	Jay Flatley	CEO	Sell	20,000	$78.07	$1,561,400.00	399,509
8/7/2013	David Walt	Director	Sell	5,000	$78.29	$391,450.00	941,488
8/2/2013	Michel Bouchard	VP	Sell	11,465	$80.64	$924,537.60
7/25/2013	Christian O Henry	SVP	Sell	11,462	$80.89	$927,161.18
7/25/2013	Jay T Flatley	CEO	Sell	20,000	$81.01	$1,620,200.00
7/24/2013	David R Walt	Director	Sell	4,600	$81.44	$374,624.00
7/24/2013	Gregory Heath	SVP	Sell	209,533	$82.00	$17,181,706.00
7/24/2013	Michel Bouchard	VP	Sell	9,789	$79.28	$776,071.92
7/15/2013	Nicholas Naclerio	SVP	Sell	2,000	$74.50	$149,000.00
7/11/2013	Jay T Flatley	CEO	Sell	20,000	$74.90	$1,498,000.00
7/11/2013	Mostafa Ronaghi	SVP	Sell	24,000	$74.95	$1,798,800.00
7/10/2013	David R Walt	Director	Sell	5,000	$74.26	$371,300.00
7/10/2013	Michel Bouchard	VP	Sell	3,618	$74.30	$268,817.40
7/9/2013	Christian O Henry	SVP	Sell	9,000	$74.01	$666,090.00
6/27/2013	Jay T Flatley	CEO	Sell	20,000	$74.96	$1,499,200.00
6/26/2013	David R Walt	Director	Sell	5,000	$75.36	$376,800.00
6/26/2013	Michel Bouchard	VP	Sell	4,272	$75.06	$320,656.32
6/25/2013	Tristan Orpin	SVP	Sell	35,000	$71.98	$2,519,300.00
6/17/2013	Nicholas Naclerio	SVP	Sell	2,000	$68.56	$137,120.00
6/14/2013	Christian O Henry	SVP	Sell	25,959	$68.10	$1,767,807.90
6/13/2013	Jay T Flatley	CEO	Sell	20,000	$66.49	$1,329,800.00
6/13/2013	Tristan Orpin	SVP	Sell	47,667	$66.55	$3,172,238.85
6/12/2013	David R Walt	Director	Sell	5,000	$67.67	$338,350.00
6/12/2013	Michel Bouchard	VP	Sell	5,170	$68.64	$354,868.80
6/11/2013	Mostafa Ronaghi	SVP	Sell	24,000	$69.01	$1,656,240.00
6/3/2013	Karin Eastham	Director	Sell	10,000	$70.34	$703,400.00
5/31/2013	Mark L Lewis	SVP	Sell	13,000	$71.72	$932,360.00
5/30/2013	Matthew L Posard	SVP	Sell	2,836	$70.80	$200,788.80
5/29/2013	David R Walt	Director	Sell	5,000	$70.92	$354,600.00
5/29/2013	Michel Bouchard	VP	Sell	6,276	$71.02	$445,721.52
5/21/2013	Jay T Flatley	CEO	Sell	24,000	$69.39	$1,665,360.00
5/20/2013	Marc Stapley	CFO	Sell	2,843	$73.38	$208,619.34
5/15/2013	David R Walt	Director	Sell	5,000	$70.73	$353,650.00
5/15/2013	Michel Bouchard	VP	Sell	14,241	$70.71	$1,006,981.11
5/15/2013	Nicholas Naclerio	SVP	Sell	2,000	$70.72	$141,440.00
5/13/2013	Mostafa Ronaghi	SVP	Sell	24,000	$68.83	$1,651,920.00
5/10/2013	Tristan Orpin	SVP	Sell	25,000	$69.60	$1,740,000.00
5/9/2013	Jay T Flatley	CEO	Sell	20,000	$66.63	$1,332,600.00
5/7/2013	Tristan Orpin	SVP	Sell	5,000	$65.68	$328,400.00
4/8/2013	Christian Cabou	SVP	Sell	16,500	$55.00	$907,500.00
4/8/2013	Marc Stapley	CFO	Sell	9,175	$55.00	$504,625.00
4/8/2013	William H Rastetter	Director	Sell	20,000	$54.95	$1,099,000.00
3/11/2013	Marc Stapley	CFO	Sell	4,468	$53.71	$239,976.28
11/8/2012	Jay T Flatley	CEO	Sell	5,000	$47.99	$239,950.00

(Data available from 1/1/2013 forward)

Illumina (NASDAQ ILMN) News Headlines

Source:

Date	Headline
	Abbott Presents Positive Study Results for Tendyne Device finance.yahoo.com - May 25 at 3:46 PM
	5 Top Efficient Stocks to Keep on Your Radar finance.yahoo.com - May 25 at 3:46 PM
	AbbVie's Imbruvica's Phase III Study Meets Primary Endpoint finance.yahoo.com - May 25 at 10:07 AM
	Kaskela Law LLC Announces Investigation of Illumina, Inc. on Behalf of Stockholders finance.yahoo.com - May 25 at 10:07 AM
	FY2018 Earnings Forecast for Illumina Issued By William Blair (ILMN) www.americanbankingnews.com - May 25 at 7:37 AM
	Why is Illumina (ILMN) Up 13.5% Since Its Last Earnings Report? finance.yahoo.com - May 24 at 10:32 AM
	Abbott Gets FDA Nod for XIENCE Sierra, To Boost Vascular Wing finance.yahoo.com - May 24 at 10:32 AM
	Q2 2018 EPS Estimates for Illumina (ILMN) Raised by William Blair www.americanbankingnews.com - May 24 at 7:56 AM
	Dr. Reddy's (RDY) Q4 Earnings Fall, Revenues Decline Y/Y finance.yahoo.com - May 23 at 3:46 PM
	Medtronic (MDT) Q4 Earnings: Can Spine Division Turn Around? finance.yahoo.com - May 23 at 3:46 PM
	Illumina (ILMN) Director Sells $269,800.00 in Stock www.americanbankingnews.com - May 22 at 7:46 PM
	AstraZeneca's Lokelma Gains FDA Nod to Treat Hyperkalemia finance.yahoo.com - May 21 at 3:43 PM
	Mostafa Ronaghi Sells 10,000 Shares of Illumina (ILMN) Stock www.americanbankingnews.com - May 18 at 10:17 PM
	5 Things Every Illumina Investor Needs to Know finance.yahoo.com - May 18 at 11:45 AM
	Form 4 ILLUMINA INC For: May 14 Filed by: deSouza Francis A www.streetinsider.com - May 17 at 10:36 AM
	Illumina (ILMN) Director Jay T. Flatley Sells 1,460 Shares www.americanbankingnews.com - May 16 at 10:31 PM
	Illumina (ILMN) CEO Sells $564,123.00 in Stock www.americanbankingnews.com - May 16 at 10:16 PM
	Roche's Actemra Gets FDA Nod for Subcutaneous Formulation finance.yahoo.com - May 15 at 3:44 PM
	Illumina buys Edico Genome seekingalpha.com - May 15 at 11:55 AM
	BRIEF-Illumina Acquires Edico Genome To Accelerate Genomic Data Analysis www.reuters.com - May 15 at 11:03 AM
	Illumina (ILMN) Acquires Edico Genome www.streetinsider.com - May 15 at 11:03 AM
	Illumina (ILMN) Expected to Announce Quarterly Sales of $783.77 Million www.americanbankingnews.com - May 15 at 4:40 AM
	Illumina (ILMN) Expected to Post Earnings of $1.10 Per Share www.americanbankingnews.com - May 13 at 3:19 AM
	Should You Be Tempted To Sell Illumina Inc (NASDAQ:ILMN) At Its Current PE Ratio? finance.yahoo.com - May 10 at 10:39 AM
	5 Winning Stocks With Superb Efficiency Level finance.yahoo.com - May 10 at 10:39 AM
	Luna DNA Raises $4 Million Including Key Investors Illumina Ventures and Arch Venture Partners www.prnewswire.com - May 8 at 3:43 PM
	Today's Research Reports on Trending Tickers: Sorrento Therapeutics and Illumina finance.yahoo.com - May 8 at 10:13 AM
	Illumina (ILMN) Receives Average Rating of "Buy" from Analysts www.americanbankingnews.com - May 7 at 3:36 PM
	Illumina Stock Upgraded: What You Need to Know www.fool.com - May 7 at 2:31 PM
	Illumina (ILMN) Rating Increased to Overweight at Barclays www.americanbankingnews.com - May 7 at 1:15 PM
	Illumina (ILMN) EVP Sells $318,776.40 in Stock www.americanbankingnews.com - May 4 at 7:52 PM
	Illumina (ILMN) Director A Blaine Bowman Sells 3,000 Shares www.americanbankingnews.com - May 3 at 7:52 PM
	Leerink Swann Comments on Illumina's Q2 2018 Earnings (ILMN) www.americanbankingnews.com - April 30 at 1:54 AM
	EQUITY ALERT: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties By Management of Illumina ... www.businesswire.com - April 29 at 10:29 AM
	Q3 2019 EPS Estimates for Illumina Raised by Analyst (ILMN) www.americanbankingnews.com - April 27 at 10:24 AM
	Illumina (ILMN) Expected to Earn Q3 2018 Earnings of $1.12 Per Share www.americanbankingnews.com - April 27 at 8:50 AM
	Zacks: Analysts Expect Illumina (ILMN) Will Announce Quarterly Sales of $770.42 Million www.americanbankingnews.com - April 27 at 2:38 AM
	Illumina (ILMN) Downgraded by ValuEngine to "Hold" www.americanbankingnews.com - April 26 at 2:04 PM
	FY2018 EPS Estimates for Illumina (ILMN) Boosted by Analyst www.americanbankingnews.com - April 26 at 10:22 AM
	Q2 2018 EPS Estimates for Illumina Boosted by Analyst (ILMN) www.americanbankingnews.com - April 26 at 9:06 AM
	$1.10 EPS Expected for Illumina (ILMN) This Quarter www.americanbankingnews.com - April 25 at 5:14 PM
	Illumina (ILMN) Q1 2018 Earnings Conference Call Transcript www.fool.com - April 25 at 4:10 PM
	Illumina (ILMN) Beats on Q1 Earnings, Lifts '18 Guidance www.nasdaq.com - April 25 at 3:43 PM
	Illumina Inc. First-Quarter Results: NovaSeq Still the Gift That Keeps on Giving www.fool.com - April 25 at 3:43 PM
	Illumina (ILMN) Beats on Q1 Earnings, Lifts '18 Guidance finance.yahoo.com - April 25 at 3:43 PM
	Illumina's (ILMN) Hold Rating Reiterated at Barclays www.americanbankingnews.com - April 25 at 1:30 PM
	Illumina (ILMN) Price Target Raised to $180.00 www.americanbankingnews.com - April 25 at 11:07 AM
	Illumina Inc. Q1 adjusted earnings Beat Estimates www.nasdaq.com - April 25 at 10:50 AM
	Illumina Reports Financial Results for First Quarter of Fiscal Year 2018 www.businesswire.com - April 25 at 10:50 AM
	BRIEF-Illumina Inc GAAP Earnings Per Share $1.41 www.reuters.com - April 25 at 10:50 AM

Illumina (NASDAQ:ILMN) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Illumina (NASDAQ:ILMN) Income Statement, Balance Sheet and Cash Flow Statement

Illumina (NASDAQ ILMN) Stock Chart for Saturday, May, 26, 2018

Loading chart…

This page was last updated on 5/26/2018 by MarketBeat.com Staff